Efficacy of different therapeutic regimens on hepatic osteodystrophy in chronic viral liver disease

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 12, 2011, Pages 1206-1212

  Yurci, Alper ^a   Kalkan, Ali Osman ^a   Ozbakir, Omer ^a   Karaman, Ahmet ^a   Torun, Edip ^a   Kula, Mustafa ^a   Baskol, Mevlut ^a   Gursoy, Sebnem ^a   Yucesoy, Mehmet ^a   Bayram, Fahri ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

chronic hepatitis; cirrhosis; hepatic osteodystrophy

Indexed keywords

ALENDRONIC ACID; CALCIUM; RISEDRONIC ACID; SALCATONIN; VITAMIN D;

ADULT; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ESOPHAGUS VARICES; FEMALE; FEMUR NECK; FOLLOW UP; HEPATIC OSTEODYSTROPHY; HUMAN; LIVER CIRRHOSIS; LUMBAR SPINE; MALE; OSTEODYSTROPHY; PRIORITY JOURNAL; RADIUS; TREATMENT RESPONSE; VIRUS HEPATITIS;

ABSORPTIOMETRY, PHOTON; ADULT; ALENDRONATE; BIOLOGICAL MARKERS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; CALCITONIN; CHRONIC DISEASE; ETIDRONIC ACID; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VITAMIN D;

EID: 80955148933     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32834cd6f6     Document Type: Article

References (26)

1. Compston JE. Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. Gut 1986; 27:1073-1090. (Pubitemid 16053541)
2. Rouillard S, Lane NE. Hepatic osteodystrophy. Hepatology 2001; 33: 301-307. (Pubitemid 32016914)
3. Leslie WD, Bemstein CN, LeBoff MS. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 2003; 125:941-966. (Pubitemid 37070710)
4. Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, Mundi JL, Femandez-Perez R, Rodrigo-Moreno D. Bone mineral density, serum insulin like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998; 28:695-699. (Pubitemid 28405418)
5. Hay JE. Bone disease in cholestatic liver disease. Gastroenterology 1995; 108:276-283.
6. Mitchison HC, Maleolm AJ, Bassendine MF, James OFW. Metabolic bone disease in primary biliary cirrhosis at presentation. Gastroenterology 1988; 94:463-470. (Pubitemid 18054786)
7. Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S. Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 1989; 96:213-221. (Pubitemid 19046285)
8. Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG, Riggs BL. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 1985; 103:855-860. (Pubitemid 16175495)
9. Chappard D, Plantard P, Fraisse H, Palle S, Alexandre C, Riffat G. Bone changes in alcoholic cirrhosis of the liver. Path Res Pract 1989; 184: 480-485.
10. Diamond T, Stiel D, Lunzer M, Wilkinson M, Roche J, Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut 1990; 31:82-87. (Pubitemid 20037985)
11. Guichelaar MMJ, Malinchoc M, Sibonga J, Clarke BL, Hay JE. Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry. Hepatology 2002; 36:895-903.
12. Hay JE. Osteoporosis in liver diseases and after liver transplantation. J Hepatol 2003; 38:856-865. (Pubitemid 36613356)
13. Collier JD, Ninkovic M, Compston JE. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 2002; 50 (Suppl 1):i1-i9. (Pubitemid 41185465)
14. Stepan JJ. Techniques for measuring bone mineral density. Int Congress Ser 2002; 1229:63-68.
15. Miller PD, Zapalowski C, Kulak CA, Bilezikian LP. Bone densitometry: the best way to detect osteoporosis and to monitor therapy. J Clin Endocrinol Metab 1999; 84:1867-1871. (Pubitemid 30647000)
16. Duarte MP, Farias LM, Coelho HS, Mendonça LM, Stabnov LM, do Carmo d Oliveira M, et al. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol 2001; 16:1022-1027. (Pubitemid 32947145)
17. Lindor KD, Jorgensen RA, Tiegs RD, Khosla S, Dickson ER. Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial. J Hepatol 2000; 33:878-882.
18. Guañabens N, Parés A, Ros I, Alvarez L, Pons F, Caballería L, et al. Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. Am J Gastroenterol 2003; 98:2268-2274. (Pubitemid 37305369)
19. Zein CO, Jorgensen RA, Clarke B, Wenger DE, Keach JC, Angulo P, Lindor K, et al. Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled study. Hepatology 2005; 42:762-771. (Pubitemid 41401113)
20. Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C. Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 2002; 23:570-578. (Pubitemid 34925651)
21. Hosking D, Adami S, Felsenberg D, Andia JC, Välimäki M, Benhamou L, et al. Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomized, placebo-controlled study. Curr Med Res Opin 2003; 19:383-394. (Pubitemid 37006371)
22. Arase Y, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Kawamura Y, et al. Prolonged efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease. J Med Virol 2008; 80: 1302-1307. (Pubitemid 351706012)
23. Tannirandorn P, Epstein S. Drug induced bone loss. Osteoporos Int 2000; 11:637-659.
24. Camisasca M, Crosignani A, Battezzati PM, Albisetti W, Grandinetti G, Pietrogrande L, et al. Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis. Hepatology 1994; 20:633-637. (Pubitemid 24271271)
25. Matloff DS, Kaplan MM, Neer RM, Goldberg MJ, Bitman W, Wolfe HJ. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxy vitamin D3 treatment. Gastroenterology 1982; 83:97-102. (Pubitemid 12123695)
26. Rizzoli R, Greenspan SL, Bone G, Schnitzer TJ, Watts NB, Adami S, et al. Two-years results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis. J Bone Miner Res 2002; 17:1988-1996. (Pubitemid 35239200)